230 related articles for article (PubMed ID: 32921595)
1. Two-Year Outcomes of Endovascular Interventions of the Common Femoral Artery: A Retrospective Analysis From Two Medical Centers.
Shammas NW; Shammas GA; Karia R; Khalafallah R; Jones-Miller S; Shammas AN
Cardiovasc Revasc Med; 2021 Mar; 24():72-76. PubMed ID: 32921595
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
Imran HM; Hyder ON; Soukas PA
Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
[TBL] [Abstract][Full Text] [Related]
3. Shockwave™ Lithoplasty in Combination With Atherectomy in Treating Severe Calcified Femoropopliteal and Iliac Artery Disease: A Single-Center Experience.
Radaideh Q; Shammas NW; Shammas WJ; Shammas GA
Cardiovasc Revasc Med; 2021 Jan; 22():66-70. PubMed ID: 32563711
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE).
Shammas NW; Shammas GA; Jones-Miller S; Shammas WJ; Bou-Dargham B; Shammas AN; Banerjee S; Rachwan RJ; Daher GE
Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):771-777. PubMed ID: 30420096
[TBL] [Abstract][Full Text] [Related]
5. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
Foley TR; Cotter RP; Kokkinidis DG; Nguyen DD; Waldo SW; Armstrong EJ
Catheter Cardiovasc Interv; 2017 May; 89(6):1078-1085. PubMed ID: 28295971
[TBL] [Abstract][Full Text] [Related]
6. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Common Femoral Artery Atherosclerotic Disease.
Stavroulakis K; Schwindt A; Torsello G; Beropoulis E; Stachmann A; Hericks C; Bollenberg L; Bisdas T
J Endovasc Ther; 2018 Feb; 25(1):92-99. PubMed ID: 29251204
[TBL] [Abstract][Full Text] [Related]
7. Safety and effectiveness of Phoenix atherectomy for endovascular treatment in calcified common femoral artery lesions.
Kronlage M; Erbel C; Lichtenberg M; Heinrich U; Katus HA; Frey N; Giusca S; Korosoglou G
Vasa; 2021 Sep; 50(5):378-386. PubMed ID: 34155913
[No Abstract] [Full Text] [Related]
8. Registry Assessment of Peripheral Interventional Devices objective performance goals for superficial femoral and popliteal artery peripheral vascular interventions.
Bertges DJ; White R; Cheng YC; Sun T; Ramkumar N; Goodney PP; Wilgus RW; Lottes AE; Smale JA; Drozda J; Raska M; Heise T; Jones WS; Tcheng JE; Eldrup-Jorgensen J; Sedrakyan A; Malone ML; Marinac-Dabic D; Thatcher R; Morales P; Krucoff MW; Cronenwett JL;
J Vasc Surg; 2021 May; 73(5):1702-1714.e11. PubMed ID: 33080324
[TBL] [Abstract][Full Text] [Related]
9. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
[TBL] [Abstract][Full Text] [Related]
10. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis.
Kokkinidis DG; Hossain P; Jawaid O; Alvandi B; Foley TR; Singh GD; Waldo SW; Laird JR; Armstrong EJ
J Endovasc Ther; 2018 Feb; 25(1):81-88. PubMed ID: 29219030
[TBL] [Abstract][Full Text] [Related]
11. Acute procedural outcomes of orbital atherectomy for the treatment of common femoral artery disease: Sub-analysis of the CONFIRM Registries.
Lee MS; Heikali D; Mustapha J; Adams G; Mahmud E
Vasc Med; 2017 Aug; 22(4):301-306. PubMed ID: 28548625
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous common femoral artery interventions using angioplasty, atherectomy, and stenting.
Mehta M; Zhou Y; Paty PS; Teymouri M; Jafree K; Bakhtawar H; Hnath J; Feustel P
J Vasc Surg; 2016 Aug; 64(2):369-379. PubMed ID: 27763265
[TBL] [Abstract][Full Text] [Related]
13. Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center.
Shammas NW; Shammas GA; Helou TJ; Voelliger CM; Mrad L; Jerin M
Cardiovasc Revasc Med; 2012; 13(4):224-7. PubMed ID: 22575073
[TBL] [Abstract][Full Text] [Related]
14. Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions.
Kokkinidis DG; Jawaid O; Cantu D; Martinsen BJ; Igyarto Z; Valle JA; Waldo SW; Armstrong EJ
J Endovasc Ther; 2020 Jun; 27(3):492-501. PubMed ID: 32364000
[No Abstract] [Full Text] [Related]
15. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.
Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
J Endovasc Ther; 2018 Feb; 25(1):109-117. PubMed ID: 29264999
[TBL] [Abstract][Full Text] [Related]
16. Auryon Laser in Peripheral Arterial Interventions: A Single-Center Experience (Auryon-SCE).
Shammas NW; Shammas GA; Halupnik G; Fedele N; Comp K; Taleb EM; Jones-Miller S; Shammas AN; Shankarraman V
J Invasive Cardiol; 2022 Jun; 34(6):E428-E432. PubMed ID: 35551106
[TBL] [Abstract][Full Text] [Related]
17. Directional Atherectomy Is Associated with Better Long-Term Efficiency Compared with Angioplasty for Common Femoral Artery Occlusive Disease in Rutherford 2-4 Patients.
Guo J; Guo L; Tong Z; Gao X; Wang Z; Gu Y
Ann Vasc Surg; 2018 Aug; 51():65-71. PubMed ID: 29501593
[TBL] [Abstract][Full Text] [Related]
18. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
[TBL] [Abstract][Full Text] [Related]
19. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
Giannopoulos S; Kokkinidis DG; Jawaid O; Behan S; Hossain P; Alvandi B; Foley TR; Singh GD; Waldo SW; Armstrong EJ
Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634
[TBL] [Abstract][Full Text] [Related]
20. JetStream Atherectomy for the Treatment of In-Stent Restenosis of the Femoropopliteal Segment: One-Year Results of the JET-ISR Study.
Shammas NW; Petruzzi N; Henao S; Armstrong EJ; Shimshak T; Banerjee S; Latif F; Eaves B; Brothers T; Golzar J; Shammas GA; Jones-Miller S; Christensen L; Shammas WJ
J Endovasc Ther; 2021 Feb; 28(1):107-116. PubMed ID: 32885736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
